Primobolan
$90.00
Primobolan (100 mg/mL) is the injectable version of the steroid methenolone. It is the same compound as Primobolin (methenolone acetate) with an enanthate ester added, resulting in a slow and gradual release of the compound from the injection site.
| Quantity | Discount | Discounted price |
| 10 - 24 | 20% | $72.00 |
| 25 - 49 | 30% | $63.00 |
| 50 - 99 | 40% | $54.00 |
Clinical Pharmacology
Primobolan (100 mg/mL) is the injectable version of the steroid methenolone. It is the same compound as Primobolin (methenolone acetate) with an enanthate ester added, resulting in a slow and gradual release of the compound from the injection site. Its activity is similar to testosterone enanthate, with blood levels remaining elevated for approximately two weeks. Primobolan is a long acting anabolic compound, with low androgenic properties. Its anabolic effects are mild, with potency slightly less than nandrolone decanoate. Since Primobolan does not readily convert to estrogen, estrogen related side effects are not exhibited. Primobolan does not significantly interfere with endogenous testosterone production except at high dosages.
| Contents | Each 10 mL multi-dose vial contains 100 mg per mL of methenolone enanthate. |
|---|---|
| Storage | Vials should be stored between 20° to 25°C (68° to 77°F). Protect from sources of heat and light. |
| Dosage and Administration | Primobolan (100 mg/mL) is for intramuscular use only. It should not be given intravenously. Intramuscular injections should be given deep in the gluteal muscle. The suggested dosage for Primobolan varies depending on the age, sex, and diagnosis of the individual patient. Dosage is adjusted according to the patient's response and the appearance of adverse reactions. Some experts have advocated lower dosages initially, gradually increasing the dose with or without a decrease to maintenance levels. Other experts emphasize higher initial dosages and lower dosages for maintenance therapy. Typical dosage range for males is 100-200 mg per week. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Warming and shaking the vial should redissolve any crystals that may have formed during storage at low temperatures. |
Reviews
There are no reviews yet.